Explore Patlytics for Patent Searches and Claim Analysis

1. What practical problem does Patlytics address?

The concrete job for this product is patent research, FTO, invalidity and cited claim charts. Evidence basis: the provider's current public material linked below. A useful first review would be: Select one claim and one candidate product feature; compare each claim element against independently checked evidence rather than accepting an automated chart. The question for patent counsel, IP teams and research-led companies is whether the output remains traceable to the original record and its authorized reviewer.

The supplier describes: Patlytics describes patent infringement, invalidity, freedom-to-operate, SEP analysis, prosecution support and patent portfolio tools. Rather than adopting it for every legal task, identify the source file, the team member responsible for reviewing the outcome, and the place where that result will be recorded. The trial should test the limitation: A cited claim chart is not a conclusive infringement opinion; claim construction, jurisdictions and unlocated evidence require attorney review.

Product role: patent research, FTO, invalidity and cited claim charts. Evidence basis: the provider's current public material linked below. Product availability and feature scope may vary by account and jurisdiction.

2. What the provider actually offers

Patlytics describes patent infringement, invalidity, freedom-to-operate, SEP analysis, prosecution support and patent portfolio tools.

Why the distinction matters: A cited claim chart is not a conclusive infringement opinion; claim construction, jurisdictions and unlocated evidence require attorney review.

An ordinary supplier demonstration should be followed by the specific sample described here: Select one claim and one candidate product feature; compare each claim element against independently checked evidence rather than accepting an automated chart. Capture the observed output, the source version and whether the result satisfies this check: Check database coverage, grant status, family members, legal history, evidence date and confidentiality of invention materials. Provider claims and test results must remain separate.

3. Practical example: a sensible first test {#practical-example}

Select one claim and one candidate product feature; compare each claim element against independently checked evidence rather than accepting an automated chart.

Repeat the same sample under the same user permissions, with the source file locked to a known version. Ask another reviewer to test check database coverage, grant status, family members, legal history, evidence date and confidentiality of invention materials. Document disagreements in the original document rather than relying on the generated summary.

A test worth retaining: Check database coverage, grant status, family members, legal history, evidence date and confidentiality of invention materials.

4. What makes this option distinct?

Where the product is positioned: patent research, FTO, invalidity and cited claim charts. Evidence basis: the provider's current public material linked below. Provider-described functionality: Patlytics describes patent infringement, invalidity, freedom-to-operate, SEP analysis, prosecution support and patent portfolio tools. Its fit should be tested by the actual work it performs, not by assuming it can substitute for a different category of legal software.

5. What should a careful organization verify?

Before using real matters, establish the access controls, retention arrangements and professional review for patent research, FTO, invalidity and cited claim charts. Evidence basis: the provider's current public material linked below. The practical failure to test is: A cited claim chart is not a conclusive infringement opinion; claim construction, jurisdictions and unlocated evidence require attorney review. A responsible review should leave both the document version and the reviewer’s correction available for inspection.

6. How to evaluate it against other tools

Compare other tools only if they can attempt the same task: Select one claim and one candidate product feature; compare each claim element against independently checked evidence rather than accepting an automated chart. Give each candidate the same source materials and the same test condition—Check database coverage, grant status, family members, legal history, evidence date and confidentiality of invention materials. Report the observed differences rather than declaring a universal winner.

Consider these four selection tests:

• Fit: Is the product genuinely intended for patent research, FTO, invalidity and cited claim charts?
• Inputs: Can you lawfully provide the documents and source records it requires?
• Output: Will the professional receive a useful, understandable and verifiable result?
• Control: Can the team inspect, correct or stop actions before an external consequence occurs?

7. Evaluation checklist {#evaluation-checklist}

• Does each claim element map to verified disclosure or prior art?
• Which patent family, publication and legal status was used?
• Could a generated amendment or figure introduce new matter?
• Can counsel inspect the underlying cited technical passage?

Product-specific check: Check database coverage, grant status, family members, legal history, evidence date and confidentiality of invention materials.

Stop condition: A cited claim chart is not a conclusive infringement opinion; claim construction, jurisdictions and unlocated evidence require attorney review. If the organization cannot answer those questions from official documents, a controlled test and its own policies, record the decision as pending rather than treating a positive product description as sufficient.

8. Frequently asked questions

Is Patlytics a legal adviser?

The supplier-described feature is a drafting or workflow aid, not a transfer of legal responsibility. The responsible specialist must review the source document and approve consequential output.

Is it suitable for confidential client documents?

That cannot be decided from this page. Confirm the applicable contract terms, data rights, retention settings, jurisdiction, legal professional duties and administrator-controlled access before entering client material.

Does this page mean TechCorpLegal is a partner or reseller?

No. This is an independent educational guide. No partnership, endorsement, provider authorization, formal product assessment or TechCorpLegal implementation service is asserted.

Can we rely on its outputs without checking them?

9. Fit, safeguards and next step

Likely readership: patent counsel, IP teams and research-led companies. Best starting point: Select one claim and one candidate product feature; compare each claim element against independently checked evidence rather than accepting an automated chart. Review boundary: A cited claim chart is not a conclusive infringement opinion; claim construction, jurisdictions and unlocated evidence require attorney review.

Keep a brief decision sheet for patent research, FTO, invalidity and cited claim charts. Evidence basis: the provider's current public material linked below: source record, first-run result, finding on “Check database coverage, grant status, family members, legal history, evidence date and confidentiality of invention materials”, corrections, approved reviewer and unresolved limitation. An untested feature remains a research candidate.

Next action on this page: Revisit the practical test or review the checklist. These are on-page navigation links, not unapproved forms or lead collection.

10. Sources, dates and limitations

• Official product or help resource: https://www.patlytics.ai/
• Further official resource: https://claude.com/marketplace/connectors/patlytics

Source status: Supplier-published capabilities reviewed against public documentation on 29 October 2026. This is not independent hands-on testing; account-specific access, quality, data-use controls, exact regional support and commercial service capability remain unverified. Permanent URLs, public CTAs, structured data and release permissions have not been authorized.